Aandelen in “Farmaceutische producten: Andere”

Aandeel Datum Koers Evolutie
vlag FitLife Brands Inc 8/09 9,770 USD
-0,51% 		-0,51%

Nieuws over “Farmaceutische producten: Andere”

13:30 · Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation · Persbericht

13:30 · Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation · Persbericht

13:05 · Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business · Persbericht

8/09 · Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets · Persbericht

7/09 · Did BellRing Brands, Inc. Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

7/09 · Virbac : Declaration of the number of shares and voting rights 08/2026 · Persbericht

7/09 · Virbac : Declaration of the number of shares and voting rights 07/2026 · Persbericht

5/09 · BellRing Brands Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BellRing Brands, Inc. - BRBR · Persbericht

4/09 · Brusselse beurs: het wankele huis van Atenor · Tijd.be (€)

De Europese beurzen doen het kalmpjes aan. UCB en Argenx wegen op de Bel20, terwijl de koers van Atenor naar een dieptepunt zakt.

2/09 · Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences · Persbericht

2/09 · Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders · Persbericht

2/09 · Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk · Persbericht

1/09 · Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test · Persbericht

1/09 · Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia · Persbericht

1/09 · Decibel Announces Commencement of Trading Following its 15:1 Share Consolidation · Persbericht

1/09 · Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference · Persbericht

31/08 · BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update · Persbericht

31/08 · Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA · Persbericht

28/08 · BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement · Persbericht

27/08 · Perrigo to Attend the Barclays Global Consumer Conference · Persbericht

27/08 · Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners · Persbericht

Mijn selecties